Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment

Detalhes bibliográficos
Autor(a) principal: Assis, Jéssica Vieira de
Data de Publicação: 2022
Outros Autores: Soares, Priscilla Filgueiras, Martins, Priscila Fernanda, Corsini, Camila Amormino, Gomes, Sarah Vieira Contin, Miranda, Daniel Alvim Pena de, Queiroz, Rafaella Fortini Grenfell e
Tipo de documento: Artigo de conferência
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/52285
Resumo: Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
id CRUZ_b187ae1ca4fe93d0a91886da0f4fb3d4
oai_identifier_str oai:www.arca.fiocruz.br:icict/52285
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Assis, Jéssica Vieira deSoares, Priscilla FilgueirasMartins, Priscila FernandaCorsini, Camila AmorminoGomes, Sarah Vieira ContinMiranda, Daniel Alvim Pena deQueiroz, Rafaella Fortini Grenfell e2022-04-14T18:15:06Z2022-04-14T18:15:06Z2022ASSIS, J. V. et al. Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 55.https://www.arca.fiocruz.br/handle/icict/5228510.35259/isi.2022_52285Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.engFiocruz/Instituto de Tecnologia em ImunobiológicosCOVID-19VacinaPacientes imunocomprometidosCOVID-19VaccineImmunocompromised patientsCâncerVacinasAnalysis of vaccine efficacy against COVID-19 in oncology patients under active treatmentinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/52285/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALAnais6thISI2022_55.pdfAnais6thISI2022_55.pdfapplication/pdf127125https://www.arca.fiocruz.br/bitstream/icict/52285/2/Anais6thISI2022_55.pdff2c3b71c7975b9e8bdb1382280b65375MD52icict/522852023-04-26 16:55:52.952oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-04-26T19:55:52Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment
title Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment
spellingShingle Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment
Assis, Jéssica Vieira de
COVID-19
Vacina
Pacientes imunocomprometidos
COVID-19
Vaccine
Immunocompromised patients
Câncer
Vacinas
title_short Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment
title_full Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment
title_fullStr Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment
title_full_unstemmed Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment
title_sort Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment
author Assis, Jéssica Vieira de
author_facet Assis, Jéssica Vieira de
Soares, Priscilla Filgueiras
Martins, Priscila Fernanda
Corsini, Camila Amormino
Gomes, Sarah Vieira Contin
Miranda, Daniel Alvim Pena de
Queiroz, Rafaella Fortini Grenfell e
author_role author
author2 Soares, Priscilla Filgueiras
Martins, Priscila Fernanda
Corsini, Camila Amormino
Gomes, Sarah Vieira Contin
Miranda, Daniel Alvim Pena de
Queiroz, Rafaella Fortini Grenfell e
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Assis, Jéssica Vieira de
Soares, Priscilla Filgueiras
Martins, Priscila Fernanda
Corsini, Camila Amormino
Gomes, Sarah Vieira Contin
Miranda, Daniel Alvim Pena de
Queiroz, Rafaella Fortini Grenfell e
dc.subject.other.pt_BR.fl_str_mv COVID-19
Vacina
Pacientes imunocomprometidos
topic COVID-19
Vacina
Pacientes imunocomprometidos
COVID-19
Vaccine
Immunocompromised patients
Câncer
Vacinas
dc.subject.en.pt_BR.fl_str_mv COVID-19
Vaccine
Immunocompromised patients
dc.subject.decs.pt_BR.fl_str_mv Câncer
Vacinas
description Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
publishDate 2022
dc.date.accessioned.fl_str_mv 2022-04-14T18:15:06Z
dc.date.available.fl_str_mv 2022-04-14T18:15:06Z
dc.date.issued.fl_str_mv 2022
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/conferenceObject
format conferenceObject
status_str publishedVersion
dc.identifier.citation.fl_str_mv ASSIS, J. V. et al. Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 55.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/52285
dc.identifier.doi.none.fl_str_mv 10.35259/isi.2022_52285
identifier_str_mv ASSIS, J. V. et al. Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 55.
10.35259/isi.2022_52285
url https://www.arca.fiocruz.br/handle/icict/52285
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/52285/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/52285/2/Anais6thISI2022_55.pdf
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
f2c3b71c7975b9e8bdb1382280b65375
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009249682325504

Registros relacionados